Showing results (31-40 of 154) with videos related to
Sort By:
Pageof 16
Expert Review of Hematology|March 12, 2019
Can increased immunogenicity in chronic myeloid leukemia improve outcomes?Onyee Chan, Chetasi Talati, Kendra Sweet, et al.Immunotherapy|April 29, 2015
An update on current and prospective immunotherapies for chronic lymphocytic leukemiaJosephine N Emole, Frederick L Locke, Javier Pinilla-IbarzFuture Oncology (London, England)|September 26, 2018
Ponatinib in the treatment of chronic myeloid leukemia and philadelphia chromosome positive acute lymphoblastic leukemiaCarolina Pavlovsky, Onyee Chan, Chetasi Talati, et al.Leukemia Research Reports|October 19, 2020
A case report and case review: Chronic myeloid leukemia (CML) blast phase with myelomastocytic differentiationJinming Song, Kenian Liu, Javier Pinilla-Ibarz, et al.Advances in Hematology|August 14, 2012
Molecular action of lenalidomide in lymphocytes and hematologic malignanciesJessica M McDaniel, Javier Pinilla-Ibarz, P K Epling-BurnetteSeminars in Hematology|February 4, 2003
Novel targeted and immunotherapeutic strategies in chronic myeloid leukemiaJoseph Schwartz, Javier Pinilla-Ibarz, Rui Rong Yuan, et al.Haematologica|October 13, 2005
Synthetic peptide analogs derived from bcr/abl fusion proteins and the induction of heteroclitic human T-cell responsesJavier Pinilla-Ibarz, Tatyana Korontsvit, Victoriya Zakhaleva, et al.Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
Signaling networks associated with BCR-ABL-dependent transformationLori A Hazlehurst, Nadine N Bewry, Rajesh R Nair, et al.Frontiers in Cell and Developmental Biology|May 2, 2025
Impact of mitochondrial metabolism on T-cell dysfunction in chronic lymphocytic leukemiaWael Gamal, Melanie Mediavilla-Varela, Vishaal Kunta, et al.Case Reports in Hematology|January 8, 2026
Successful Zanubrutinib Monotherapy in a Rare CNS Presentation of Relapsed CLLVishaal Kunta, Mohammad Ammad-Ud-Din, Melanie Mediavilla-Varela, et al.Pageof 16